Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: Assessment of protective effects in a rat model

International Journal of Urology

Volumn 19, Issue 12, 2012, Pages 1108-1112

  Tasdemir, Seda ^a   Tasdemir, Cemal ^a   Vardi, Nigar ^a   Yakupogullari, Yusuf ^a   Duman, Yucel ^a   Parlakpinar, Hakan ^a   Sagir, Mustafa ^a   Acet, Ahmet ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Bladder instillations; Chondroitin sulfate; Hyaluronic acid; Urinary tract infection

Indexed keywords

CHONDROITIN SULFATE; HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIUM CULTURE; BLADDER; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFECT; EPITHELIUM; ESCHERICHIA COLI; FEMALE; GROWTH RATE; NONHUMAN; PRIORITY JOURNAL; RANDOM SAMPLE; RAT; THICKNESS; TISSUE CULTURE; URINARY TRACT INFECTION; URINE CULTURE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ANALYSIS OF VARIANCE; ANIMALS; CHONDROITIN SULFATES; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HYALURONIC ACID; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; URINARY BLADDER; URINARY TRACT INFECTIONS; URINE; UROTHELIUM;

EID: 84870295707     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2012.03109.x     Document Type: Article

References (21)

1. Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010; 7: 653-60.
2. Kronenberg A, Koenig S, Droz S, Mühlemann K. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting. Clin. Microbiol. Infect. 2011; 17: 1845-51.
3. Karlowsky JA, Lagacé-Wiens PRS, Simner PJ etal. Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study. Antimicrob. Agents Chemother. 2011; 55: 3169-75.
4. Poggi MM, Johnstone PA, Conner RJ. Glycosaminoglycan content of human bladders: a method of analysis using cold-cup biopsies. Urol. Oncol. 2000; 5: 234-7.
5. Porru D, Leva F, Parmigiani A etal. Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int. Urogynecol. J. 2011; DOI: 10.1007/s00192-011-1546-5
6. Damiano R, Cicione A. The role of sodium hyaluronate and sodium chondroitin sulphate in the management of bladder disease. Ther. Adv. Urol. 2011; 3: 223-32.
7. Bhavanandan VP, Erickson DR. An investigation of the nature of bladder mucosal glycoconjugates and their role in interstitial cystitis. Indian J. Biochem. Biophys. 1997; 34: 205-11.
8. Lee D-G, Cho J-J, Park HK etal. Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. Urology 2010; 75: 949-54.
9. Tay H, Parsons CL, Stein PC. Electrophysiologic monitoring of the effects of soluble virulence factors produced by Escherichia coli infection in urine. Urology 1996; 48: 389-92.
10. Parsons CL, Greenspan C, Moore SW, Mulholland SG. Role of surface mucin in primary antibacterial defense of bladder. Urology 1977; 9: 48-52.
11. Parsons CL, Mulholland SG. Bladder surface mucin. Its antibacterial effect against various bacterial species. Am. J. Pathol. 1978; 93: 423-32.
12. Parsons CL, Shrom SH, Hanno PM, Mulholland SG. Bladder surface mucin. Examination of possible mechanisms for its antibacterial effect. Invest. Urol. 1978; 16: 196-200.
13. Shrom SH, Parsons CL, Mulholland SG. Role of urothelial surface mucoprotein in intrinsic bladder defense. Urology 1977; 9: 526-33.
14. Sobeslavsky O, Prescott B, Chanock RM. Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence. J. Bacteriol. 1968; 96: 695-705.
15. Hanno PM, Parsons CL, Shrom SH, Fritz R, Mulholland SG. The protective effect of heparin in experimental bladder infection. J. Surg. Res. 1978; 25: 324-9.
16. Parsons CL. Bladder surface glycosaminoglycan: efficient mechanism of environmental adaptation. Urology 1986; 27 (2 Suppl): 9-14.
17. Kaufman JE, Anderson K, Parsons CL. Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis. Urology 1987; 30: 255-8.
18. Daha LK, Riedl CR, Hohlbrugger G etal. Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study. J. Urol. 2003; 170: 807-9.
19. Leppilahti M, Hellström P, Tammela TLJ. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 2002; 60: 46-51.
20. Kyker KD, Coffman J, Hurst RE. Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder. BMC Urol. 2005; 5: 4.
21. Nishimura M, Yan W, Mukudai Y etal. Role of chondroitin sulfate-hyaluronan interactions in the viscoelastic properties of extracellular matrices and fluids. Biochim. Biophys. Acta 1998; 1380: 1-9.